Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Cardiology
Big bigCover of Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

More books from Springer US

bigCover of the book Computer-Based Diagnostics and Systematic Analysis of Knowledge by
bigCover of the book Advances in Microbial Toxin Research and Its Biotechnological Exploitation by
bigCover of the book Magnetic Resonance in Experimental and Clinical Oncology by
bigCover of the book Ultrasound Interactions in Biology and Medicine by
bigCover of the book Advances in Food Process Engineering Research and Applications by
bigCover of the book Introduction to Forensic Psychology by
bigCover of the book Sibling Relationships Across the Life Span by
bigCover of the book Optimization for Decision Making by
bigCover of the book Outcome-Based Evaluation by
bigCover of the book AIDS Education by
bigCover of the book Handbook of Interpersonal Commitment and Relationship Stability by
bigCover of the book Callosal Agenesis by
bigCover of the book Computer-Supported Collaborative Learning at the Workplace by
bigCover of the book Metallization of Polymers 2 by
bigCover of the book Divorce in Europe by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy